Navigation Links
WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
Date:9/29/2008

&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com

Statements contained in this press release, which are not historical facts, such as statements about the timing for opening of, and the anticipated benefits of, the GLP facility (currently under construction) and the range of offered services are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein are based largely on WuXi management's expectations and actual results could vary significantly. The anticipated timing for opening the GLP facility and the nature of the offered services could change. Success of the facility and the ability to offer world-class preclinical toxicology services are subject to other risks and uncertainties including, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, WuXi's ability to build and staff the facility, obtain the required certifications and to market and provide the services in China, and other factors described in WuXi's filings with the U.S. Securities and Exchange Commission. WuXi undertakes no duty to update any forward looking statement to conform the statement to actual results or changes in expectations.

For more information, please contact:

Debra Yu, MD

Vice President Strategy

WuXi PharmaTech (Cayman) Inc.

Tel: +1-215-218-5559

Email: ir@wuxiapptec.com


'/>"/>
SOURCE WuXi PharmaTech
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. WuXi PharmaTech Promotes Dr. Rujian Ma to VP of Synthetic Chemistry
2. Warburg Pincus Acquires 5.4% of WuXi PharmaTechs Outstanding Ordinary Shares from United Overseas Bank
3. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
4. WuXi PharmaTech (NYSE: WX) Appoints Dr. Debra Yu as VP of Strategy
5. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
6. WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
7. Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal
8. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
9. WuXi PharmaTech (NYSE: WX) Expands Collaboration With AstraZeneca
10. Quest PharmaTech Announces Positive Results from Phase I Clinical Trial of its Photodynamic Therapy for Actinic Keratosis
11. WuXi PharmaTech Announces First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... -- Decision Resources, one of the world,s leading ... issues, finds that, owing to the launches of ... will increase more than sevenfold from $790 million ... the United States, France, Germany, Italy, Spain, the ... report entitled Atrial Fibrillation finds that ...
(Date:12/14/2009)... - Results From a Survey Conducted by UCB Assessing ... Countries , , - A third of ... impacts their enjoyment of the festive season, ... shopping for gifts, preparing holiday ... difficult to do, - Nearly ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) announced today ... offering have exercised in full their option to ... at the public offering price of $24.75 per ... the size of the offering to an aggregate ... expects to receive net proceeds from the offering ...
(Date:12/11/2009)... new explanation for differences in the severity of mental illness ... the more serious the handicap. The genetic defect is situated ... the amount of copies of the GDI1 gene that is ... Journal of Human Genetics , and are the result of ... a life sciences research institute in Flanders, Belgium at the ...
Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Amount of gene surplus determines severity of mental retardation in males 2
... March 13 Covance Inc. (NYSE: ... its clinical pharmacology footprint in Europe with the ... research company based in Basel, Switzerland."Our clients, need ... help them make decisions faster is growing," said ...
... 13 Varian Medical Systems (NYSE: VAR ) ... non-destructive testing market at the upcoming ASNT Research Symposium and ... Hotel in St. Louis, MO.The company will exhibit a number ... , A ...
... Some of the world,s most respected energy experts will be exploring ... the Energy Capital of the World, as the Greater Houston Partnership ... policy by hosting "America,s Energy Future: Assessing Our Paths to Energy ... ...
Other Biology Technology:Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site 2Varian Medical Systems to Exhibit X-ray and CT Technologies for Non-Destructive Testing at the Upcoming ASNT 18th Annual Spring Conference 2Greater Houston Partnership to Lead Energy Security Discussion 2
(Date:12/14/2009)... HOUSTON -- (Dec. 14, 2009) -- Researchers at Rice ... a single nanoparticle that can be tracked in real ... cells, tags them with a fluorescent dye and kills ... the first examples from a growing field called "theranostics" ... treat diseases in a single procedure. , The research ...
(Date:12/14/2009)... and the Biomedical Engineering Society (BMES) have founded a ... CVET ). CVET is a forum ... medical treatment. The first issue of the new ... two other BMES publications at Springer, Annals of ... . , Cardiovascular Engineering and Technology will ...
(Date:12/14/2009)... once thought of tool use as a defining feature of ... other primates, along with birds and an array of other ... Current Biology , a Cell Press publication, adds an ... veined octopus under study manages a behavioral trick that the ... itself over stacked, upright coconut shell "bowls," makes its eight ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Biomedical Engineering Society's new journal to be published by Springer 2Tool use in an invertebrate: The coconut-carrying octopus 2Swine Flu Infection Rates Continue to Fall 63147 1Swine Flu Infection Rates Continue to Fall 63147 2Swine Flu Infection Rates Continue to Fall 63147 3Abbott Declares 344th Consecutive Quarterly Dividend 63144 1Childrens Hospital Surgeon Receives Prestigious Paul Tessier Medal 63141 1Childrens Hospital Surgeon Receives Prestigious Paul Tessier Medal 63141 2
... years of near-zero growth in atmospheric methane concentrations, levels ... good news for future global warming," says CSIRO,s Dr ... in Geophysical Research Letters, a journal of the American ... important greenhouse gases, namely methane and the CFCs, had ...
... L-1 to Open 75+ Centers and Expects to Process ... Requiring,Fingerprint-based Background Checks, STAMFORD, Conn., Oct. 29 ... provider of identity solutions and,services, was selected by the ... a,five-year contract estimated at up to $250 million to ...
... Whether it,s in the human body or under the ... Physicians and geologists will be meeting at the University of ... , Through a partnership between UH, M.D. Anderson ... seismic imaging will gather to explore the potential for cross-collaboration ...
Other Biology News:Global methane levels on the rise again 2L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million 2L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million 3L-1 Identity Solutions Selected by the State of New York as the Winning Bidder to Provide Enrollment Services for a Contract Estimated at Up to $250 Million 4Similarities in imaging the human body, Earth's crust focus of conference at UH 2
ID clarifier: With ethidium bromide (50 μg/ml)...
... C2C12 cells were cultured in DMEM and harvested ... order to keep the antigens in their native ... cells are arrayed on a 12-well (5 mm) ... treated to enhance cellular attachment and to minimize ...
... for optimal colony growth; ... growth of anchorage-dependent cells. ... colony-forming assays of human ... Not suitable for long-term ...
... is a convenient, premixed, formamide-containing ... and Perfect RNA Markers. This ... dilution and is suitable for ... mix equal volumes of RNA ...
Biology Products: